Sep
14
2:00 pm14:00

Coté Orphan Inside Track Road Show - San Francisco

  • TBD

Coté Orphan Road Show will include key players of the regulatory affairs industry. Attendees will learn first-hand how orphan drugs are managed with special deference by regulatory agencies such as the FDA and EMA. This one-day seminar is a unique and free opportunity to hear from the former head of the FDA orphanage just how things are viewed from the inside. 

Sep
26
7:00 am07:00

RESI Boston

  • Boston Marriott Copley Place

The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels. The conference helps facilitate face to face meetings between companies and investors based on a common fit (indication, technology & stage of development) which promotes compelling conversations, facilitating the development of qualified investor to entrepreneur relationships. The RESI Conference also serves as an excellent opportunity for large pharma/ medtech companies and service providers to connect with attending companies and investors representing their portfolio companies.

Sep
26
Sep 27

BioPharm America

  • Sheraton Boston Hotel
BPA---10th-annual-e5d6947820922a48661861304dfb2181.png

BioPharm America propels the future of drug development.

The event brings you unequaled value and unparalleled access to global decision makers in an elevated format that highlights innovation.


Jun
19
Jun 22

2017 BIO International Convention - San Diego, CA

he BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

May
21
May 24

DIA China Annual Meeting

  • Shanghi International Convention Center
On May 21-24, 2017, the DIA China Annual Meeting will bring together global pharmaceutical professionals to discuss critical topics and themes surrounding the regulation, discovery, development, and life cycle management of health care products.

The DIA China Annual Meeting will bring together global pharmaceutical professionals to discuss critical topics and themes surrounding the regulation, discovery, development, and life cycle management of health care products.

May
10
May 11

NewYorkBio Annual Conference

  • Park @ Time Warner Center

Each year the event draws over 1,000 attendees from New York and across the Northeast, as well as a global audience including attendees from Europe and Asia.

The theme of the 2017 Annual Conference is "New York Life Science at a Tipping Point." 

Over the past several years, the New York life science ecosystem has seen huge growth in industry development, venture investment, commercial expansion, and patient relations. But it has taken a long time to get this point, and the industry has had some significant set backs. The 2017 Annual Conference will therefore be a frank and open discussion of the issues—the good, the bad, and the ugly—of New York’s life science scene as it exists today and what may be the strengths, weaknesses, opportunities, and threats to it. What have we done right? What have we done wrong? What lessons can be learned and applied?

Source: http://www.newyorkbio.org/

Coté Orphan Inside Track Road Show - NYC
May
9
2:00 pm14:00

Coté Orphan Inside Track Road Show - NYC

  • 3 West Club

Coté Orpan Boot Camp will include key players of the regulatory affairs industry. Attendees will learn first-hand how orphan drugs are managed with special deference by regulatory agencies such as the FDA and EMA. This one-day seminar is a unique and free opportunity to hear from the former head of the FDA orphanage just how things are viewed from the inside. Meet us there! 

May
4
9:00 am09:00

Swiss BioTech Day 2017

  • Congress Center

The Swiss Biotech Day has long become the standard annual get-together of the Swiss bio­pharmaceutical industry. And Basel, as one of the most vivid cities in terms of biotechnological and pharmaceutical research, development and production, proved to be the ideal location.

Now in its 19th year, the SBD is not just the place to be for members of the Swiss Biotech Association, who traditionally meet there for the association’s Annual General Assembly. As always, the event targets entrepreneurs, investors, researchers, analysts, political decision makers and industry stakeholders.

May
3
2:00 pm14:00

Coté Orphan Boot Camp - Basel, Switzerland

  • Ramada Plaza Basel Hotel & Conference Center

Coté Orphan Boot Camp will include key players of the regulatory affairs industry. Attendees will learn first-hand how orphan drugs are managed with special deference by regulatory agencies such as the FDA and EMA. This one-day seminar is a unique and free opportunity to hear from the former head of the FDA orphanage just how things are viewed from the inside. 

Apr
19
Apr 21

World Orphan Drug Congress USA 2017

  • Wardman Park Marriott

At the World Orphan Drug Congress USA in April 2017, we are bringing together more than 150 elite speakers to educate and inspire our 1,000 attendees from big pharma, biotech, payers, patient groups, academics and government bodies. In 2017, World Orphan Drug Congress USA is bringing together the worlds of Scientific Innovation and Commercialization, with 2 tracks in the main conference. 

By exploring trends in Digital Health, Biosimilars, Gene Therapy, and more, we will uncover the next scientific breakthrough. Examinations of Mergers, Commercialization, Marketing and the Regional Markets will provide insight into this billion-dollar business. That's not all with Rare Disease Advocacy World and Pitch and Partner 2017, there are 4 tracks of content for you and your team to enjoy. 

- See more at: http://www.terrapinn.com/conference/world-orphan-drug-congress-usa/index.stm#sthash.3XNgFgaf.dpuf

Apr
18
2:00 pm14:00

Coté Orphan Inside Track Road Show

  • FHI 360 Conference Center

Coté Orpan Road Show will include key players of the regulatory affairs industry. Attendees will learn first-hand how orphan drugs are managed with special deference by regulatory agencies such as the FDA and EMA. This half-day seminar is a unique and free opportunity to hear from the former head of the FDA orphanage just how things are viewed from the inside.

Apr
12
Apr 14

BIO Korea 2017

  • Korea

The 12th anniversary of leading Korean bio-industry’s future.

BIO KOREA isan effective business place has galvanised into bio-industry.  Also, It is the place of the international information exchange and technology Transfer.

Apr
4
9:00 am09:00

RESI Conference - Toronto, Canada

  • MaRS Discovery District

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.

Mar
30
Mar 31

2017 MassBio Annual Meeting

  • Cambridge, MA

The MassBio Annual Meeting focuses on the timeliest and critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.

Mar
20
Mar 22

BIO-Europe Spring 2017

  • CCIB Convention Center

The premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters

Mar
14
Mar 15

BIO Asia International Conference 2017

  • Grand Hyatt

The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market. 

Mar
8
Mar 10

Orphan Drugs & Rare Diseases Global Congress 2017 Europe

  • Millennium Gloucester Hotel

The conference will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organisations, orphan drugs developers as well as regional and local manufacturers. We are putting together an agenda that address the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally including commercialisation, policies, reimbursement, pricing and more.

Mar
1
Mar 2

Biocom's Global Life Science Partnering Conference

  • The Lodge at Torrey Pines

Biocom's 7th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.

The conference will include panel discussions on relevant topics with senior industry leaders, start-up company presentations, one-on-one meetings, and numerous networking opportunities.

Coté Orphan Boot Camp - La Jolla, CA/Torrey Pines
Feb
28
2:00 pm14:00

Coté Orphan Boot Camp - La Jolla, CA/Torrey Pines

  • The Lodge at Torrey Pines

Coté Orpan Boot Camp will include key players of the regulatory affairs industry. Attendees will learn first-hand how orphan drugs are managed with special deference by regulatory agencies such as the FDA and EMA. This one-day seminar is a unique and free opportunity to hear from the former head of the FDA orphanage just how things are viewed from the inside. Ask here for more details. 

Feb
10
3:00 pm15:00

Coté Orphan LLC Boston Grand Opening Event

  • Avalon North Point

Cote Orphan LLC is excited to announce its newest location in Boston/Cambridge, MA. Please come and enjoy an evening of networking with Dr. Tim Cote, the Boston staff, and biotech industry leading partners to learn about consultant services available.

Jan
10
9:00 am09:00

RESI Conference 2017

  • San Francisco, CA

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more.

Meet us there!

Source: http://www.resiconference.com/

Jan
9
Jan 11

Biotech Showcase 2017

  • Hilton San Francisco Union Square

Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.

Meet us there! 

Source: https://ebdgroup.knect365.com/biotech-showcase/

Jan
8
Jan 11

JP Morgan Health Care Conference 2017

  • San Francisco, CA

This event continues to be one of the life science industry’s largest conferences of the year. It brings thousands of investors and executives from around the world to San Francisco where companies present their latest innovations hoping to find their next partner or investor.

Meet us there!

Source: http://www.biopharminsight.com/events/35th-annual-jp-morgan-healthcare-conference

 

Dec
7
Dec 9

Oncolytic Virotherapy Summit 2016

  • San Diego, CA

The 2nd Annual Oncolytic Virotherapy Summit is dedicated to foster the next wave of genetically modified viruses that target, replicate and kill cancer cells in a clinical setting, spurred on by advanced genetic engineering techniques.

By better understanding oncolytic platforms, preclinical virotherapy models, clinical strategy and scalable manufacture of viruses, Oncolytic Virotherapy Summit is the only industry-focused gatheringallowing you to capitalize on this inflection point and enhance the translation of innovative basic research into the next generation of clinically-relevant virotherapeutics.

Global Summit on Rare Diseases & Orphan Drugs
Nov
16
Nov 17

Global Summit on Rare Diseases & Orphan Drugs

The (GROD 2016) Global Summit on Rare Diseases & Orphan Drugs is an International Rare Diseases Conference, encompassing genetically caused rare diseases and fundamental research and development in respective field. It is a Global platform reaching across all the rare diseases around the globe, covers research and developments of new treatments. The conference attains significance when we look at the worldwide deaths due to Rare Diseases, about 30 percent of children with rare diseases will die before reaching their fifth birthday. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in 'Dubai' a capital city of united arab emirates, and a promising place to discover novel things in the field of science and technology.

5th Oncology Partnering & Deal-Making
Nov
8
Nov 9

5th Oncology Partnering & Deal-Making

We invite you to attend the 5th Oncology Partnering & Deal-Making Conference, which will take place November 8-9, 2016 in San Francisco, CA. This event is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry. 

Experts in the field of oncology will present on the latest discoveries, novel technologies, business development trends, markets, innovative partnering for value creation, and landscape of Immuno-oncology. There will be a mix of presentations and interactive panel discussions so join your business development colleagues at this unique partnering forum! 

Bio Europe - Fall
Nov
7
Nov 9

Bio Europe - Fall

  • Cologne Germany

The 22nd annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.

This year´s BIO-Europe partnering event will again draw over 3,000 industry attendees from nearly 60 countries, representing more than 1,800 companies for three days of high level networking. Meet us there! 
 

ExL Events - Priority Review Voucher Summit
Nov
3
8:00 am08:00

ExL Events - Priority Review Voucher Summit

The Priority Review Voucher Program was created as an incentive for pharmaceutical companies to develop drugs for neglected diseases. In order to receive a priority review voucher (PRV), a product application must meet the criteria of the Neglected Tropical Disease or Rare Pediatric Disease PRV Programs. Neglected tropical diseases are infectious diseases that affect more than a billion people in 149 countries, most of which are in the developing world. A rare pediatric disease is a disease that affects fewer than 200,000 individuals in the United States, of which greater than 50% of the affected population is 18 or under.

Bio Network West
Oct
5
Oct 7

Bio Network West

  • The Ritz-Carlton

BioNetwork is a platform for business development executives across the pharmaceutical and biotechnology space to come together in an intimate setting and develop relationships that lead to strategic partnerships. Meet us there! 

Nordic Life Sciences Day
Sep
14
Sep 15

Nordic Life Sciences Day

The Nordic region is proud to host some of the world’s most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest.  Set in the idyllic city of Stockholm, the conference offers conference sessions, panel discussions, company presentations, exhibition, face-to-face meetings and unique receptions, providing so many opportunities to network with peers, potential partners and investors. Meet us there! 

BioPharm America
Sep
13
Sep 15

BioPharm America

  • Boston Marriott Copley Place

BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Meet us there! 

The Inside Track to Orphan Drug Designation
Aug
2
1:00 pm13:00

The Inside Track to Orphan Drug Designation

Dr. Tim Cote will be hosting a webinar outlining: 

  • The differences in obtaining approval for orphan vs. non-orphan drugs
  • Detail prevalent criteria for orphan drugs
  • The clinical superiority in orphan drug designation
  • What is a “typical orphan drug”

For more information and a VIP discount code, contact us here

Orphan Drugs & Rare Diseases Americas
Jun
28
Jun 29

Orphan Drugs & Rare Diseases Americas

  • Boston, MA USA

Orphan Drugs & Rare Diseases Global Congress 2016 Americas will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, nonprofit organizations, orphan drugs developers as well as regional and local manufacturers.  
 

  • Tim Coté will be speaking at 12:00pm on June 29th
  • Tim Coté and Brian Dwyer will be speaking on panels at 4:20pm and 5:00pm on the 29th, respectively